Editorial issue 262

This 262th issue of NDT-Edu starts with 5 very recent papers, all from NDT. The first three ones discuss some implications of the recent KDIGO Guidelines for CKD. Using the educational PRO /CON format, R.J. Glassock on the one hand, and G. Conte et al. on the other hand, align the arguments in favour and against the use of age-dependent thresholds to define chronic kidney disease. In the accompanying commentary entitled “Should we diagnose CKD using the one-size fits all KDIGO 2012 guideline or do we need a more complex age-specific classification system”, S.I. Hallan and R.T.Gansevoort propose a tentative synthesis of this highly relevant issue. No doubt these relatively short papers dealing with an important topic for any nephrologist (in fact any doctor) will be of interest to many NDT-E readers.
The 4th paper by Krummel T. et al. is entitled: Haemodialysis in patients treated with oral anticoagulant: should we heparinize?
Finally, R Agarwal et al. report a randomized controlled trial of hypertension treatment in hemodialysis patients with atenolol or lisinopril. Here again an important topic and one piece of useful information in an incredibly unexplored field!

Then, this 262TH issue gives you the opportunity to enjoy 4 CME lectures from the ERA-EDTA Istanbul congress. The topic of the first one, presented by Dr. Mahmut Ilker Yilmaz (Ankara, Turkey) is “Inflammation, CKD-MBD and endothelial dysfunction”. In the second one, Prof. Alberto Ortiz (Madrid, Spain) presents recent data on “Kidney inflammation and CKD-MBD regulatory molecules”. In the third one, Dr. Juan-Jesus Carrero-Roig (Stockholm, Sweden) discusses the “Epidemiology linking inflammation and CKD-MBD”. Finally, Prof. Peter Blankestijn (Utrecht, The Netherlands) deals with another current hot topic: the rationale for renal denervation.


Enjoy NDT-E


Prof. Michel Jadoul
Editor-in-Chief NDT-Educational